Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The question of dosing is central to your success
Investigating the association between GLP-1 receptor agonists and mood disorders: a study integrating real-world data and Mendelian randomization
Most notably, the patients enrolled in LEADER had chronic cardiovascular risk (either a pre-existing cardiovascular condition or a high risk for cardiovascular disease), while only those individuals who were within 180 days post-acute coronary event and, hence, at the highest risk of a further cardiovascular event, were included in ELIXA
Start low, monitor response over several days (not hours), and adjust slowlythis mirrors the way dose escalation is approached in Phase 1 trials where uncertainty is high and safety is the priority
Summary Maintaining total-, low-density lipoprotein (LDL)-, and high-density lipoprotein (HDL)-cholesterol within healthy ranges is important for reducing atherosclerotic plaque formation and the risk of coronary heart disease (CHD)
